Status:
UNKNOWN
Investigating the Role of Biomarkers in Predicting Outcome for COVID 19
Lead Sponsor:
University of British Columbia
Conditions:
COVID 19
Eligibility:
All Genders
Brief Summary
Emergent experimental and anecdotal evidence has indicated that critically ill COVID-19 patients demonstrate two patient sub-types (called phenotypes). In one group the disease progresses slowly and p...
Detailed Description
PURPOSES 1. Determine the prevalence of a COVID-19 hyper-inflammatory "cytokine storm" phenotype in patients at Vancouver General Hospital 2. Determine any potential links between cytokine storm and ...
Eligibility Criteria
Inclusion
- Patients admitted to VGH or SMH with confirmed COVID-19
- Admitted to the High Acuity Unit or Intensive Care Unit at VGH or SMH
- An arterial line is in place as part of clinical care. If arterial line is on longer insitu the sample will be collected to coincide with usual care blood collection. This will negate the need for additional venipuncture
Exclusion
- Those who do not meet inclusion criteria
Key Trial Info
Start Date :
March 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04363008
Start Date
March 30 2020
End Date
September 30 2024
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vancouver General Hospital
Vancouver, British Columbia, Canada, V5Z 1M9